OpenURL Connection Search

Select item for more details and to access through your institution.

Topotecan in combination with cisplatin for the treatment of stage IVB recurrent, or persistent cervical cancer.
Published in:
2006
By:
- Brave M;
- Dagher R;
- Farrell A;
- Abraham S;
- Ramchandani R;
- Gobburu J;
- Booth B;
- Jiang X;
- Sridhara R;
- Justice R;
- Pazdur R
Publication type:
Journal Article
Essential Pharmacokinetic Information for Drug Dosage Decisions: A Concise Visual Presentation in the Drug Label.
Published in:
Clinical Pharmacology & Therapeutics, 2011, v. 90, n. 3, p. 471, doi. 10.1038/clpt.2011.149
By:
- Menon-Andersen, D.;
- Yu, B.;
- Madabushi, R.;
- Bhattaram, V.;
- Hao, W.;
- Uppoor, R. S.;
- Mehta, M.;
- Lesko, L.;
- Temple, R.;
- Stockbridge, N.;
- Laughren, T.;
- Gobburu, J. V.
Publication type:
Article
ASCPT Task Force for Advancing Pharmacometrics and Integration into Drug Development.
Published in:
Clinical Pharmacology & Therapeutics, 2010, v. 88, n. 2, p. 158, doi. 10.1038/clpt.2010.141
By:
- Goldberger, M. J.;
- Singh, N.;
- Allerheiligan, S.;
- Gobburu, J. V. S.;
- Lalonde, R.;
- Smith, B.;
- Ryder, S.;
- Yozviak, A.
Publication type:
Article
Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma.
Published in:
Clinical Pharmacology & Therapeutics, 2010, v. 88, n. 1, p. 115, doi. 10.1038/clpt.2010.64
By:
- Jang, S. H.;
- Colangelo, P. M.;
- Gobburu, J. V. S.
Publication type:
Article
Elucidation of Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug Development.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 2, p. 167, doi. 10.1038/clpt.2009.64
By:
- Wang, Y.;
- Sung, C.;
- Dartois, C.;
- Ramchandani, R.;
- Booth, B. P.;
- Rock, E.;
- Gobburu, J.
Publication type:
Article
Biomarkers in Clinical Drug Development.
Published in:
2009
By:
- Gobburu, J. V. S.
Publication type:
Opinion
Pharmacometrics at FDA: Evolution and Impact on Decisions.
Published in:
Clinical Pharmacology & Therapeutics, 2007, v. 82, n. 1, p. 97, doi. 10.1038/sj.clpt.6100234
By:
- Powell, J. R.;
- Gobburu, J. V. S.
Publication type:
Article
Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006.
Published in:
Clinical Pharmacology & Therapeutics, 2007, v. 81, n. 2, p. 213, doi. 10.1038/sj.clpt.6100051
By:
- Bhattaram, V. A.;
- Bonapace, C.;
- Chilukuri, D. M.;
- Duan, J. Z.;
- Garnett, C.;
- Gobburu, J. V. S.;
- Jang, S. H.;
- Kenna, L.;
- Lesko, L. J.;
- Madabushi, R.;
- Men, Y.;
- Powell, J. R.;
- Qiu, W.;
- Ramchandani, R. P.;
- Tornoe, C. W.;
- Wang, Y.;
- Zheng, J. J.
Publication type:
Article
Dose-response relationship characterization in current anti-hypertensive drug development.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P68, doi. 10.1016/S0009-9236(03)90610-2
By:
- Gobburu, J. V.;
- Lipicky, R. J.
Publication type:
Article
Population pharmacokinetic (PPK) modeling and simulation-derived dosing of intravenous busulfan (Busulfex) in pediatric patients.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P66, doi. 10.1016/S0009-9236(03)90602-3
By:
- Booth, B. P.;
- Rahman, A.;
- Dagher, R. N.;
- Griebel, D.;
- Lai, A.;
- Lennon, S.;
- Fuller, D.;
- Gobburu, J. V.
Publication type:
Article
A population pharmacokinetic model for zoledronic acid (ZOMETA) in patients with bone metastases.
Published in:
Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P67, doi. 10.1016/S0009-9236(03)90605-9
By:
- Booth, B. P.;
- Rahman, A.;
- Ibrahim, A.;
- Scher, N.;
- Williams, G.;
- Schran, H.;
- Ma, P.;
- Hsu, C.;
- Gobburu, J. V.
Publication type:
Article
Drugs Against Rare Diseases: Are The Regulatory Standards Higher?
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 4, p. 322, doi. 10.1002/cpt.415
By:
- Gobburu, J;
- Pastoor, D
Publication type:
Article
Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities.
Published in:
Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 1, p. 37, doi. 10.1002/cpt.7
By:
- Venkatakrishnan, K;
- Friberg, LE;
- Ouellet, D;
- Mettetal, JT;
- Stein, A;
- Trocóniz, IF;
- Bruno, R;
- Mehrotra, N;
- Gobburu, J;
- Mould, DR
Publication type:
Article
Should Pharmacometrics Be Training the Next R&D President?
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 6, p. 579, doi. 10.1038/clpt.2014.68
By:
- Gobburu, J V S
Publication type:
Article
Communicating to Influence Drug Development and Regulatory Decisions: A Tutorial.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 4, p. 163, doi. 10.1002/psp4.12073
By:
- Mehrotra, S;
- Gobburu, J
Publication type:
Article
Utilisation of pharmacokinetic-pharmacodynamic modelling and simulation in regulatory decision-making.
Published in:
2001
By:
- Gobburu, J.V.S.;
- Marroum, P.J.;
- Gobburu, J V
Publication type:
journal article
The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
Published in:
2002
By:
- Marroum, P.J.;
- Gobburu, J.;
- Marroum, Patrick J;
- Gobburu, Jogarao
Publication type:
journal article
Pharmacokinetic-Pharmacodynamic Modeling of Rivastigmine, a Cholinesterase Inhibitor, in Patients with Alzheimer's Disease.
Published in:
Journal of Clinical Pharmacology, 2001, v. 41, n. 10, p. 1082, doi. 10.1177/009127000104101006
By:
- Gobburu, J. V.S.;
- Tammara, V.;
- Lesko, L.;
- Jhee, S. S.;
- Sramek, J. J.;
- Cutler, N. R.;
- Yuan, Ruihua
Publication type:
Article
Characterizing Class-Specific Exposure-Viral Load Suppression Response of HIV Antiretrovirals Using A Model-Based Meta-Analysis.
Published in:
CTS: Clinical & Translational Science, 2016, v. 9, n. 4, p. 192, doi. 10.1111/cts.12395
By:
- Xu, Y;
- Li, YF;
- Zhang, D;
- Dockendorf, M;
- Tetteh, E;
- Rizk, ML;
- Grobler, JA;
- Lai, M‐T;
- Gobburu, J;
- Ankrom, W
Publication type:
Article
Exposure--response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma.
Published in:
Journal of Invasive Fungal Infections, 2010, v. 4, n. 4, p. 153
By:
- Jang, S. H.;
- Colangelo, P. M.;
- Gobburu, J. V.
Publication type:
Article

Found: 20